Swissmedic Asks Sponsors For At Least Four Months’ Notice Ahead Of New Drug Filings
Executive Summary
Companies looking to file medicines containing new active substances in Switzerland should notify the regulator up to six months before their planned submission date to support early planning activities, Swissmedic says.